InsiderClue
← All stocks

Estrella Immunopharma, Inc.

ESLA Net buying
CIK 0001844417 #4891 in the set updated 17 Sep 2026
Bought (120 mo)
$44.68B
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$44.68B
+$44.68B against sales at will

By person

4 insiders · 6 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Li Jianwei
Former Co-CEO and Director
$44.68B (1)
—
+$44.68B
1,253,730
2.88%
$1.67M
+12.8%
Xu Jiandong
Chief Financial Officer
$2.59K (3)
—
+$2.59K
382,188
0.8786%
$508.31K
+36.5%
Liu Cheng
CEO
—
—
—
397,437
0.9137%
$528.59K
+33.6%
Owl Creek Asset Management, L.P. entity
10% owner
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
Liu Cheng
25 Aug 2026
CEO
Exercised, kept
100,000
$0.82
$81.50K
Xu Jiandong
18 Aug 2026
Chief Financial Officer
Exercised, kept
100,000
$0.82
$81.50K
Xu Jiandong
7 Oct 2025
Chief Financial Officer
Buy
1,000
$1.33
$1.33K
Xu Jiandong
22 Sep 2025
Chief Financial Officer
Buy indirect
1,000
$1.16
$1.16K
Xu Jiandong
11 Sep 2025
Chief Financial Officer
Buy
100
$1.04
$104.00
Li Jianwei
4 Mar 2022
Co-Chief Executive Officer
Buy
141,970
$314,700.00
$44.68B

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 455,000
History held since 17 Mar 2022